A total of 122 AYA participated in 11 FGDs and 12 IDIs: 38% from Nairobi (n = 46), 37% from Kisumu (n = 45), and 25% from Mombasa (n = 31). Participant ages ranged from 15-24 years, and 57% were female (n = 70). Additional demographic details are presented in Table 1.
Table I. Participant Characteristics
Participant group
|
Type (N)
|
Site
|
Participants
N
|
Female
N (%)
|
Age range (years)
|
ALHIV
|
FGD (2)
|
Kisumu
|
19
|
11 (58)
|
15-19
|
ALHIV
|
FGD (1)
|
Mombasa
|
11
|
6 (55)
|
15-19
|
ALHIV
|
FGD (2)
|
Nairobi
|
19
|
9 (47)
|
15-19
|
Peer leaders
|
FGD (1)
|
Kisumu
|
11
|
6 (55)
|
20-24
|
Peer leaders
|
FGD (1)
|
Mombasa
|
8
|
4 (50)
|
20-24
|
Peer leaders
|
FGD (1)
|
Nairobi
|
12
|
6 (50)
|
20-24
|
AIC
|
FGD (1)
|
Kisumu
|
11
|
11 (100)
|
15-19
|
AIC
|
FGD (1)
|
Mombasa
|
8
|
0 (0)
|
15-19
|
AIC
|
FGD (1)
|
Nairobi
|
11
|
11 (100)
|
15-19
|
ALHIV
|
IDI (4)
|
Kisumu
|
4
|
2 (50)
|
16-19
|
ALHIV
|
IDI (4)
|
Mombasa
|
4
|
2 (50)
|
15-19
|
ALHIV
|
IDI (4)
|
Nairobi
|
4
|
2 (50)
|
15-18
|
Adolescents described how multiple stigma-related barriers and resilience-related facilitators, occurring at individual, interpersonal, and community levels, influenced ALHIV adherence to ART (Table II). While AIC and peer leader participants mainly focused on barriers to adherence, ALHIV adopted a strengths-based perspective. ALHIV described how they had developed resilience independently and through support systems, and how this resilience manifests in better adherence to ART and clinic attendance. Overall, we identified four major themes that describe the interplay between stigma and resilience among ALHIV. Within each thematic area, resilience was a significant theme throughout discussions with ALHIV. However, peer leader and AIC participants were less likely to recognize resilience and its contribution to stigma reduction. Peer leaders and AIC easily identified challenges that ALHIV faced, but most did not discuss how ALHIV can overcome barriers to achieve ART adherence.
Table II. Perceptions of barriers and facilitators to adolescent ART adherence by participant group
Socio-ecological model level
|
Barrier
|
ALHIV
|
AIC
|
Peer leader
|
Facilitator
|
ALHIV
|
AIC
|
Peer leader
|
Individual
|
ALHIV experience internalized stigma, which manifests in isolation and a lack of sense of belonging
|
X
|
X
|
X
|
Self-motivation and a positive attitude drive pro-health behaviors
|
X
|
|
|
Internalized stigma leads to low morale, negatively impacting ART use
|
X
|
X
|
X
|
The presence of future life goals (i.e., career goals, family goals) is a motivator for adherence
|
X
|
|
|
ALHIV constantly compare themselves to peers without HIV, negatively impacting mental health
|
X
|
|
|
Knowledge is power, and accurate knowledge of ART can improve adherence
|
X
|
|
X
|
Interpersonal
|
Many parents/families will stigmatize, mistreat, or desert ALHIV when they find out their status
|
|
X
|
X
|
Family members offer support in the form of encouragement, reminders to take ART, and help picking up medication
|
X
|
|
|
Stigmatization within families often leads to community-wide stigma
|
|
X
|
X
|
Friends are generally supportive when disclosure occurs; support includes encouragement and reminders to take ART
|
X
|
|
|
ALHIV struggle with disclosing their status due to anticipated stigma
|
X
|
X
|
X
|
Support of an HIV-positive friend or family member encourages better adherence and improves mental health
|
X
|
|
X
|
Lack of disclosure to others can lead to social withdrawal and mental health concerns (i.e., anxiety, depression)
|
X
|
|
|
Having the support of even one person (family, friend) can motivate ALHIV to engage in pro-health behaviors
|
X
|
|
X
|
ALHIV default on medication (skipping or delaying ART) due to fear of status disclosure while with friends or family
|
X
|
X
|
X
|
Disclosure is challenging, but the support received, as a result, is worth it
|
X
|
|
X
|
Disclosure to friends causes friends to stigmatize/isolate ALHIV or become overly attentive
|
|
X
|
|
|
Community
|
School classmates and teachers stigmatize ALHIV and spread gossip
|
X
|
X
|
X
|
ALHIV who seek support from school staff (headteachers, matrons, nurses) are granted permission to attend clinic appointments
|
X
|
|
|
ART medication packaging is stigmatizing (i.e., seen as a symbol of HIV) and discourages ALHIV from carrying pill bottles at school
|
X
|
X
|
X
|
In school settings, creative solutions for carrying ART discreetly facilitate adherence (ex: carrying single pills in pocket rather than pill bottle)
|
X
|
|
|
Teachers separate students with HIV from other students, causing social isolation for ALHIV in school
|
X
|
X
|
X
|
Positive relationships with HCW generate trust and encourage care-seeking among ALHIV
|
X
|
|
|
Distrust of teachers causes challenges asking for permission to attend clinic during school hours; this can lead to missed appointments
|
X
|
|
|
Peer leader encouragement and support is effective in motivating adherence, especially to attend clinic
|
X
|
|
X
|
Fear of disclosure at school makes ART adherence difficult for those whose pill regimens overlap with school hours (especially boarding school students)
|
X
|
X
|
X
|
Adolescent support groups foster peer connection, support positive mental health, and improve adherence
|
X
|
|
X
|
HCW are usually older, judgmental, cold, and unrelatable to ALHIV
|
|
X
|
X
|
|
HCW scold ALHIV who have missed appointments or have poor adherence, impacting their desire to attend clinic
|
X
|
|
X
|
This table outlines which participant groups discussed each of the above themes, to highlight each participant group’s perceptions of barriers and facilitators to ART adherence.
Self-acceptance of HIV status and future-oriented goals can drive motivation for ALHIV to remain healthy
For many ALHIV, beginning ART was challenging, especially for those adolescents who had trouble accepting their positive HIV status. Initially, fear of unknown medication and potential side effects was daunting. However, with time, ALHIV noticed the positive effects of taking ART, which motivated them to continue medication to remain healthy.
“First, before I began, I was very weak… But when I started taking the drugs, after some time, I saw some change in my skin…So I saw that the drugs were helping me…I got to know my status, and I decided: If this is what has been planned for me, I will continue to take the drugs and take care of myself.”
‒ ALHIV IDI female, Mombasa
Although it took time for many ALHIV to get used to their medication and new daily pill-taking routines, many noted that adherence became easier once they had adjusted to this change.
“If you start and just continue, it will be easy. It will be just like taking tea; you will know this is the same formula every morning or your time. You will just get used to it. A journey starts like that and when you start, just finish your race.”
‒ ALHIV FGD female, Nairobi
Despite adjusting to the routine, the majority of ALHIV described simultaneously experiencing internalized stigma, which negatively impacted mental health and lowered self-esteem. Constant comparisons to healthy peers, especially siblings or friends, led some to have difficulty accepting their status. Many adolescents who expressed mental health concerns and feelings of isolation also mentioned defaulting on medications.
Status acceptance was noted as a counterbalance to internalized stigma, with many ALHIV noting that consistent pill-taking became more manageable once they accepted their HIV status. ALHIV who accepted their HIV status trusted that they could continue to lead healthy lives with consistent ART adherence, and cited future aspirations, including educational, career, or family goals, as motivators for consistently taking ART.
“I just take them [ART pills] very fast, go to sleep, and in the morning I wake up with a lot of psyche…When I go back to sleep, I take them again. It is very easy at that point when you have something that is driving you to live. When you have something that is pulling you towards life, it is easier than when there is not a lot happening; when things are at a standstill.”
— ALHIV IDI male, Kisumu
ALHIV also recognized the importance of staying healthy for the benefit of loved ones, feeling a personal responsibility that also motivated adherence.
“I think I’ll still take my meds because there’s still a lot that I need to do; there are still a lot of people that are depending on me, and there are still a lot of people that I need to show that life can go on after this.”
— ALHIV IDI male, Kisumu
Throughout, a recurring theme was the importance of optimism and a positive outlook on life, which allowed adolescents to overcome internalized stigma and generated an internal motivation to stay healthy that facilitated ART adherence.
Disclosure to family and other trusted individuals strengthens support systems for ALHIV
A significant theme throughout the data was fear of HIV status disclosure. At least one parent or caregiver was often aware of ALHIV status early for those with perinatal HIV acquisition. However, anticipated stigma made disclosure to others difficult, leading many to hide their status from all but their closest family members. Many ALHIV made conscious decisions to disclose their status to only a select few “critical people” who they were confident would be sources of support.
“[Tell] that person the truth, but also when you are HIV positive, you can’t tell everyone. You just tell those people that you think if you tell this one there is a way he/she can help me and will not tell anybody else. In our family, it’s only four people who know. Those critical people, you show them that… it’s not the end of life, and you can make it in life.”
‒ ALHIV IDI female, Mombasa
AIC and peer leaders particularly expressed concerns that family members and friends would stigmatize ALHIV if their HIV status were disclosed. Despite this frequently endorsed fear, many ALHIV shared positive experiences with disclosure and described the support they received upon opening up to family or friends. ALHIV who had disclosed to their families noted that they were supported in their treatment adherence. Support, especially from mothers and aunts, was vital in driving resilience and motivating adherence; the role of fathers or male guardians was described less frequently. Support from family members was twofold: 1) emotional support, including encouraging them and boosting self-esteem, and 2) practical support, such as picking up their medications for them when they were unable to attend clinic or reminding them to take their ART on schedule.
“If your parent really cares about you, your status cannot hinder you at all. She will encourage you to finish the medicine, and you will be okay. She will give you the medicine and give you encouragement, examples, teachings, and education.”
‒ ALHIV FGD female, Nairobi
Friends' support varied widely and was mainly based on whether adolescents had disclosed their HIV status to friends. The vast majority of ALHIV recognized the value of disclosing to one or a select few “trustworthy” and “confidential” friends. Those who had done so described overwhelmingly positive responses to disclosing their status to friends. When disclosure did occur, friends helped adolescents adhere to ART by reminding them to take medications, keeping track of appointments, encouraging them, and providing emotional support.
“So if you tell your friend on this particular day, she reminds you to go to the clinic. So your friend can set the alarm, or she can circle a calendar. So when that day comes, she tells you that you are supposed to go to the clinic, ‘Stop what you are doing. I’ll finish it, so you just go’.”
— ALHIV FGD male, Kisumu
Some ALHIV had friends who were also HIV positive, which enabled mutual support. One ALHIV described a system she created with her friend in which they used certain code words to remind each other to take their ART, thus facilitating reminders in public without fear of inadvertent disclosure.
Strategies for discrete pill-taking and strategic disclosure can overcome challenges at school
Adolescents spend much of their time in school, an environment that adolescents described as creating specific challenges for adherence. HIV stigma in school was noted as being extremely high and could lead to peer rejection, gossip, and “special treatment” from teachers that further isolated ALHIV from others.
Often school staff, and teachers in particular, were viewed as untrustworthy and unsupportive. Most ALHIV had not disclosed their HIV status to teachers. However, teachers were described as being uninformed about HIV and lacking understanding of special needs and considerations for students living with HIV. Teachers were viewed as strict and unwavering in their school policies, which often prohibited students from carrying water or using the bathroom during class, therefore creating logistical barriers to adherence among adolescents whose pill schedules required them to take medication while in school.
ALHIV described overcoming these barriers by employing creative strategies for taking pills discreetly to avoid inadvertent status disclosure. For example, some adolescents carried pills in their pockets or socks rather than the noisy pill container, used plastic bags, or wrapped pills individually in paper. Many adolescents found ways to take pills during breaks, at the back of the classroom, or in the bathroom.
“When I went to a boarding school…I was given the idea to use the school bell, I used to use the 8 am and 8 pm bell, the morning bell was for going to the assembly, and I had my medicine ready, I would at times pretend to my friends that I am taking water so that they wait for me then we run to the assembly. The evening bell was for bathing, so I would just take my medicine at ease.”
‒ ALHIV FGD participant (unknown sex), Mombasa
Strict or inflexible school policies also created challenges for adolescents who required permission to miss class for clinic appointments. Many ALHIV stated that they had been denied permission to leave class, leading to missed appointments. To overcome these barriers, some ALHIV asked their parents to request permission from the school to attend clinic visits, and others obtained a note from the clinic or hospital to validate their request. ALHIV, who feared disclosure to staff members, sometimes resorted to missing the entire school day, later explaining to teachers that they had been sick.
Some ALHIV were able to build relationships with school staff they trusted to keep their status hidden and gain support for navigating adherence in the school setting. These school staff, most frequently school nurses or headteachers in day schools or matrons in boarding schools, supported ALHIV by allowing excused absences, storing medications, and reminding ALHIV to take their ART.
ART adherence barriers differed depending on the type of school ALHIV attended: boarding or day school. The majority’s opinion was that day schools improved adherence because they overcame the challenge of needing to hide medications while at school, as most ALHIV took medication before and after school. However, some adolescents attending boarding school felt that the routine, especially with consistent meal times, helped them maintain their ART schedule. In addition, those who felt comfortable disclosing their status to their roommates could take ART freely in their rooms, which facilitated adherence.
Regardless of the type of school they attended, ALHIV expressed a desire for schools to be more lenient in granting permission for absences. Peer leaders also recognized these barriers and some expressed a desire to attend schools to speak with students and staff with the goal of de-stigmatizing HIV and perhaps even affecting change in school policies.
A supportive clinic environment promotes continuous adolescent engagement in HIV care
Most ALHIV felt supported by their health clinics and clinic staff. ALHIV and peer leaders agreed that youth-friendly services were essential for engaging adolescents in care and providing a sense of belonging and age-specific support. Various adolescent-friendly services discussed included youth-specific clinic days, youth-friendly clinic staff (including peer support), “youth zones” (youth-specific clinics), adolescent support groups, and treatment buddy systems (an arrangement in which two ALHIV mutually support each other for ART adherence through reminders, encouragement, and shared strategies). Most ALHIV valued youth-specific clinics or clinic days, which created a more comfortable atmosphere for adolescents, and most importantly, provided confidentiality.
“You go to a place where you are comfortable; some of us are infected, and you don’t want your friends to know that you are infected. So you go to a place where it is safe; they [others] will not see you there.”
‒ ALHIV FGD female, Kisumu
Youth-specific services also allowed adolescents to meet and socialize with others who shared their status and related to their challenges. In particular, adolescent support groups allowed adolescents to share personal experiences and work through problems in a safe space:
“When we came here in the morning, we weren’t talking to each other because we don’t know each other. But [the healthcare worker] came and told us that we are the same, so we got the confidence; when I talk, I am ok, and when she talks, she is also ok. So the self-esteem and the confidence; you get encouraged, and you will be okay.”
‒ ALHIV FGD female, Nairobi
ALHIV had largely positive experiences regarding their relationships with clinic healthcare workers (HCWs) and valued clinic staff who were understanding, confidential, non-judgmental, and supportive. They wanted clinic staff with whom they could feel free to ask questions and share concerns and who encouraged them and cheered them on. This type of support helped foster trust between HCWs and adolescents, even as many ALHIV were initially wary of opening up to HCWs.
“I can say that what helped me a lot is the doctor, the good friend that I have… She keeps on encouraging me to move on and to maintain…in fact; she told me that so many people have the virus, so I’m not alone…so with that motivation, I was somewhat encouraged it was like a will that guides me to move on.”
‒ ALHIV IDI male, Kisumu
Despite the overall positive experiences with HCWs described by ALHIV, peer leaders and AIC perceived most HCWs to be cold and unsympathetic to ALHIV struggles. Some ALHIV also felt that HCWs were too strict, and described situations where HCWs scolded adolescents who had missed appointments, causing them embarrassment and impacting their willingness to attend the clinic in the future.
An essential benefit of youth-specific clinics came from peer leaders, who ALHIV described as more relatable and trustworthy than other HCWs. Peer leader presence created a welcoming atmosphere in the clinic, where ALHIV were more likely to return and felt freer in discussing their questions and concerns. Some ALHIV expressed that support from peer leaders encouraged them to take ART consistently, helping them attain an undetectable viral load.
“She [mom] would tell me to take [ART] by 8 am, but sometimes I would oversleep and miss it. So some of my bottles were full. So our counselor [the peer leader] encouraged me...told me what it [HIV] is and how to take my drugs, and since then, I am fine. My viral load came from 94k to 10k, and now it’s 150.”
‒ ALHIV FGD male, Nairobi
Peer leaders recognized their influence among adolescents and took this responsibility seriously. However, they also discussed a lack of adequate resources, compensation, and training to do their jobs effectively. They saw a more significant opportunity for positive intervention given sufficient resources and enhanced training. For example, peer leaders requested better education regarding ART, including side effects, to counteract common misinformation among adolescents. In addition, peer leaders suggested that increased home visits would help adolescents struggling with challenges such as denial of their HIV status, fear of disclosure, and internalized stigma. Though outside their traditional scope of work within clinics, peer leaders expressed a desire to work within schools as well. Though potentially logistically challenging, peer leaders felt they could engage with school staff to enhance the support provided to students living with HIV and engage with students to provide education and counteract stigma in the school setting. Most peer leaders overlooked adolescents’ resilience and strength in overcoming adherence barriers and dealing with adversity. However, peer leaders were passionate about their role in working with ALHIV and expressed a willingness and enthusiasm to learn more and establish deeper relationships with ALHIV.
Conceptual model
Our thematic analysis led to the development of a conceptual model (Figure 1) that describes how stigma and resilience interact among ALHIV accessing LVCT Health services in Kenya. The model explores how, under certain conditions (e.g., a non-supportive family environment or stigma at school), stigmatization by HIV uninfected individuals may operate to produce adverse outcomes among ALHIV. However, adolescents identified that promotive factors could moderate the adverse effects of stigmatization. The four themes discussed above are represented as four legs of a stool, and represent influencing factors in different areas of adolescents’ lives, in which ALHIV can overcome stigma and build resilience. This analogy demonstrates how ALHIV adherence is most robust when adolescents have positive influences in not one, but all four aspects of their lives: individually, from friends and family, at school, and in the clinic. For example, when adolescents possess self-motivation and are supported in their schools and health clinics and by family and friends, this can build a strong foundation for leading healthy lives. However, the presence of negative influencing factors in any one of these four contexts may upset the balance and frustrate efforts for ALHIV to achieve healthy adherence outcomes.